You just read:

Two Independent Studies of the Multiple Sclerosis (MS) Market Highlight the Increasing Penetration of Oral Disease-modifying Therapies (DMTs) into First Line Position

News provided by

Spherix Global Insights

Jan 17, 2017, 05:00 ET